Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tolerability of 3D Printed vs Liquid Hydrocortisone in Pediatrics
NCT06435481Phase 4Not yet recruiting
- Sponsor
- Vall d'Hebron Research Institute
- Start
- Sep 2024
- Primary completion
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of hydrocortisone in adrenal insufficiency (AI), sponsored by Vall d'Hebron Research Institute. Planned start Sep 2024; status: not yet recruiting.
02
Drugs
hydrocortisone
03
Conditions
adrenal insufficiency (AI)
Beyond the preview
Go deeper on NCT06435481.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06435481.